About
Pain Gel
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (8)
View allTotal Trials
8
As Lead Sponsor
6
As Collaborator
2
Total Enrollment
629
By Phase
NA: 2PHASE2: 2PHASE1: 2PHASE3: 1
By Status
COMPLETED: 5TERMINATED: 3
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT03589456Lead Sponsor
Establishment of a PDT Patient Registry
N/ATerminated
22 participants
Started: Jan 18, 2019 · Completed: Jan 15, 2020
NCT03564054Collaborator
Trial of Photodynamic Therapy Versus Argon Plasma Coagulation for Lung Cancer With Endobronchial Obstruction
NATerminated
3 participants
Started: Oct 11, 2018 · Completed: Sep 30, 2019
NCT03852459Lead Sponsor
Controlled Study to Assess the Efficacy and Safety of S-Ibuprofen Topical Gel 5% (AP0302) in the Treatment of DOMS
PHASE2Completed
251 participants
Started: Jan 12, 2018 · Completed: Apr 11, 2019
NCT03344861Lead Sponsor
Safety of PDT-Photofrin® Prior to Lung Surgery
PHASE1Completed
10 participants
Started: Aug 14, 2017 · Completed: Mar 22, 2019
NCT02916745Lead Sponsor
Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer
PHASE1Completed
5 participants
Started: Jan 26, 2017 · Completed: Apr 12, 2019
Locations (1)
Headquarters
Hampton, NH, United States
Map
Loading map...